BBS Pharmaceuticals News
Export Control Legislation Amendment (Certification of Narcotic Exports) Bill passes in Australia… - BBS Pharmaceuticals, a licensed cultivator and manufacturer of medicinal cannabis products would like to congratulate Minister David Littleproud and the… […]
Adrian Pederick MP applauds BBS on their site progress… - It has been a busy and productive start of the second quarter here at BBS Pharmaceuticals. We had the honour… […]
Regional Development Australia Murraylands & Riverland impressed with BBS’s progress - It has been a busy and incredibly productive start of the week here at BBS as we are entering the… […]
Local MP, Adrian Pederick visits BBS’s facility… - It has been a busy and productive start of the second quarter here at BBS Pharmaceuticals. We had the honour… […]
Minister for Trade and Investment, David Ridgway visits BBS’s facility - It was our great honour to host The Hon. David Ridgway, Minister of Trade and Investment, at BBS’s cultivation and… […]
Australian government unveils proposal for over-the-counter CBD - Australia has published a framework for new CBD regulations as it considers relaxing its narcotics scheduling of cannabidiol to make… […]
BBS Pharmaceuticals welcomes newly appointed Head of Sales & Marketing - Michael Kromwyk has been appointed Head of Sales and Marketing at BBS Pharmaceuticals with responsibility for brand and marketing programs,… […]
BBS’s CEO John Dagas addresses Covid -19 and moving forward… - These are challenging times as the world responds to the coronavirus outbreak and sets a path to recovery. First off,… […]
Australia’s legal cannabis market predicted to bloom to $1.5 billion by 2025 - As various phases of legalisation come into effect in different parts of Australia, the country’s cannabis market is expected to… […]
Industry Breakthough as Australian Senate Committee pushes for legalisation and increased patient access to medicinal cannabis in Australia! - The Australian Senate Committee has revealed their recommendations from the inquiry 'Current barriers to patient access to medicinal cannabis in… […]

Industry Breakthough as Australian Senate Committee pushes for legalisation and increased patient access to medicinal cannabis in Australia!

The Australian Senate Committee has revealed their recommendations from the inquiry ‘Current barriers to patient access to medicinal cannabis in Australia’. In its 118-page long document, […]

TGA to expand quality audits for medicinal cannabis…

In the coming months, the TGA will expand the number of quality audits of medicinal cannabis products imported or supplied under the Special Access Scheme (SAS) […]

Study reveals difference between labelled and actual CBD potency…

A scientific study conducted by Professor Poulas Konstantinos and his team from the Department of Pharmacy at the University of Patras in Greece, and in collaboration […]

Hundreds of seizures a day, now cannabis oil is ‘making a difference for my daughter’

Even on a good day, eight-year-old Sophie Martin has hundreds of seizures. When she has a severe seizure, she turns blue and cannot breathe. She has […]

“Don’t bring others down…”

Don’t bring others down! Message from BBS Pharmaceuticals’  CEO, John Dagas regarding the medicinal cannabis industry. “The start of 2020 has seen a number of medicinal […]

“Medicinal cannabis can be the healthcare success story of our lifetime,” says health care entrepreneur Hugh Hempel

“Medicinal cannabis can be the healthcare success story of our lifetime,” says Hugh Hempel, a technology industry veteran turned health care entrepreneur. In this moving talk, […]

‘How a cancer diagnosis inspired one of the fastest-emerging medicinal cannabis companies in the world…’

“It’s the teams that make history… Alone, we can do so little; together we can do so much.” BBS was born one night as two friends, […]

‘How a cancer diagnosis inspired one of the fastest-emerging medicinal cannabis companies in the world…’

BBS Pharmaceuticals featured in Health Europa Medical Cannabis Network’s latest issue…

World First! Yale approves investigation of the effectiveness of cannabis-based medicines…

The Food and Drug Administration (FDA) has approved a first-of-its-kind human trials study by the Yale School of Medicine in conjunction with CT Pharma that will […]